MIMETAS
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/MimetasS2.png?fit=800%2C336&ssl=1)
Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.